Cardiovascular Health : Some GLP-1 agonists have demonstrated protective effects on the cardiovascular system, reducing the risk of major adverse cardiovascular events (MACE)
If we can make the atrium a less favorable environment for AFib, ablation has a better chance to work. Next Steps: Larger Trials and Broader Applications of GLP1 Therapy While LEAF was a relatively small, singlecenter study, the magnitude of benefit observed has generated interest in larger trials to confirm the findings and determine optimal timing and duration of GLP1 therapy
But his focus has shifted now that hes in his maintenance phase
Safety Profile: Observed effects are consistent with the incretin class, including manageable gastrointestinal transitions such as nausea or mild digestive changes
The dual action of Tirzepatide effectively reduces caloric intake while improving glucose metabolism, which explains why the SURMOUNT-1 trial data showed up to a 22.5% mean weight reduction at the 72-week mark
The exact hormone therapy you will receive may be a combination or estrogen and other therapies depending on your age and symptoms
